Literature DB >> 26578438

Porphyrin-phospholipid liposomes with tunable leakiness.

Dandan Luo1, Kevin A Carter1, Aida Razi2, Jumin Geng1, Shuai Shao1, Cuiyan Lin1, Joaquin Ortega2, Jonathan F Lovell3.   

Abstract

Drug bioavailability is a key consideration for drug delivery systems. When loaded with doxorubicin, liposomes containing 5 molar % porphyrin-phospholipid (HPPH liposomes) exhibited in vitro and in vivo serum stability that could be fine-tuned by varying the drug-to-lipid ratio. A higher drug loading ratio destabilized the liposomes, in contrast to standard liposomes which displayed an opposite and less pronounced trend. Following systemic administration of HPPH liposomes, near infrared laser irradiation induced vascular photodynamic damage, resulting in enhanced liposomal doxorubicin accumulation in tumors. In laser-irradiated tumors, the use of leaky HPPH liposomes resulted in improved doxorubicin bioavailability compared to stable standard liposomes. Using this approach, a single photo-treatment with 10mg/kg doxorubicin rapidly eradicated tumors in athymic nude mice bearing KB or MIA Paca-2 xenografts.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Doxorubicin; Liposomes; Photodynamic therapy; Porphyrin; Vasculature

Mesh:

Substances:

Year:  2015        PMID: 26578438      PMCID: PMC4688124          DOI: 10.1016/j.jconrel.2015.11.011

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  47 in total

Review 1.  Enzyme-responsive nanoparticles for drug release and diagnostics.

Authors:  Roberto de la Rica; Daniel Aili; Molly M Stevens
Journal:  Adv Drug Deliv Rev       Date:  2012-01-14       Impact factor: 15.470

2.  Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents.

Authors:  Jonathan F Lovell; Cheng S Jin; Elizabeth Huynh; Honglin Jin; Chulhong Kim; John L Rubinstein; Warren C W Chan; Weiguo Cao; Lihong V Wang; Gang Zheng
Journal:  Nat Mater       Date:  2011-03-20       Impact factor: 43.841

3.  Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release.

Authors:  Dandan Luo; Kevin A Carter; Aida Razi; Jumin Geng; Shuai Shao; Daniel Giraldo; Ulas Sunar; Joaquin Ortega; Jonathan F Lovell
Journal:  Biomaterials       Date:  2015-10-23       Impact factor: 12.479

4.  Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors.

Authors:  G Canti; A Nicolin; R Cubeddu; P Taroni; G Bandieramonte; G Valentini
Journal:  Cancer Lett       Date:  1998-03-13       Impact factor: 8.679

5.  Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone.

Authors:  H J Lim; D Masin; T D Madden; M B Bally
Journal:  J Pharmacol Exp Ther       Date:  1997-04       Impact factor: 4.030

6.  Leakage of sucrose from phosphatidylcholine liposomes induced by interaction with serum albumin.

Authors:  J Zborowski; F Roerdink; G Scherphof
Journal:  Biochim Biophys Acta       Date:  1977-03-29

7.  Augmented EPR effect by photo-triggered tumor vascular treatment improved therapeutic efficacy of liposomal paclitaxel in mice bearing tumors with low permeable vasculature.

Authors:  Tomoya Araki; Ken-ichi Ogawara; Haruka Suzuki; Rie Kawai; Taka-ichi Watanabe; Tsutomu Ono; Kazutaka Higaki
Journal:  J Control Release       Date:  2014-12-29       Impact factor: 9.776

8.  Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations.

Authors:  Michael J W Johnston; Katarina Edwards; Goran Karlsson; Pieter R Cullis
Journal:  J Liposome Res       Date:  2008       Impact factor: 3.648

9.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

Authors:  M E R O'Brien; N Wigler; M Inbar; R Rosso; E Grischke; A Santoro; R Catane; D G Kieback; P Tomczak; S P Ackland; F Orlandi; L Mellars; L Alland; C Tendler
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

Review 10.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

View more
  17 in total

1.  Multifunctional Liposomes for Image-Guided Intratumoral Chemo-Phototherapy.

Authors:  Dyego Miranda; Kevin Carter; Dandan Luo; Shuai Shao; Jumin Geng; Changning Li; Upendra Chitgupi; Steven G Turowski; Nasi Li; G Ekin Atilla-Gokcumen; Joseph A Spernyak; Jonathan F Lovell
Journal:  Adv Healthc Mater       Date:  2017-05-15       Impact factor: 9.933

2.  Design of Hydrated Porphyrin-Phospholipid Bilayers with Enhanced Magnetic Resonance Contrast.

Authors:  Shuai Shao; Trang Nhu Do; Aida Razi; Upendra Chitgupi; Jumin Geng; Richard J Alsop; Boris G Dzikovski; Maikel C Rheinstädter; Joaquin Ortega; Mikko Karttunen; Joseph A Spernyak; Jonathan F Lovell
Journal:  Small       Date:  2016-10-14       Impact factor: 13.281

3.  Anticancer drug released from near IR-activated prodrug overcomes spatiotemporal limits of singlet oxygen.

Authors:  Pallavi Rajaputra; Moses Bio; Gregory Nkepang; Pritam Thapa; Sukyung Woo; Youngjae You
Journal:  Bioorg Med Chem       Date:  2016-02-21       Impact factor: 3.641

Review 4.  Carriers for the tunable release of therapeutics: etymological classification and examples.

Authors:  Vuk Uskoković; Shreya Ghosh
Journal:  Expert Opin Drug Deliv       Date:  2016-06-27       Impact factor: 6.648

5.  Advanced Functional Nanomaterials for Theranostics.

Authors:  Haoyuan Huang; Jonathan F Lovell
Journal:  Adv Funct Mater       Date:  2016-11-07       Impact factor: 18.808

6.  Metal Chelation Modulates Phototherapeutic Properties of Mitoxantrone-Loaded Porphyrin-Phospholipid Liposomes.

Authors:  Kevin A Carter; Sophie Wang; Jumin Geng; Dandan Luo; Shuai Shao; Jonathan F Lovell
Journal:  Mol Pharm       Date:  2015-12-31       Impact factor: 4.939

7.  Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.

Authors:  Liangzhu Feng; Liang Cheng; Ziliang Dong; Danlei Tao; Todd E Barnhart; Weibo Cai; Meiwan Chen; Zhuang Liu
Journal:  ACS Nano       Date:  2016-12-29       Impact factor: 15.881

8.  Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes.

Authors:  Dandan Luo; Jumin Geng; Nasi Li; Kevin A Carter; Shuai Shao; G Ekin Atilla-Gokcumen; Jonathan F Lovell
Journal:  Mol Cancer Ther       Date:  2017-07-20       Impact factor: 6.261

9.  Rapid Light-Triggered Drug Release in Liposomes Containing Small Amounts of Unsaturated and Porphyrin-Phospholipids.

Authors:  Dandan Luo; Nasi Li; Kevin A Carter; Cuiyan Lin; Jumin Geng; Shuai Shao; Wei-Chiao Huang; Yueling Qin; G Ekin Atilla-Gokcumen; Jonathan F Lovell
Journal:  Small       Date:  2016-04-28       Impact factor: 13.281

10.  Photodynamic Therapy Induced Enhancement of Tumor Vasculature Permeability Using an Upconversion Nanoconstruct for Improved Intratumoral Nanoparticle Delivery in Deep Tissues.

Authors:  Weidong Gao; Zhaohui Wang; Liwei Lv; Deyan Yin; Dan Chen; Zhihao Han; Yi Ma; Min Zhang; Man Yang; Yueqing Gu
Journal:  Theranostics       Date:  2016-05-21       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.